|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print September 18, 2002
Am J Physiol Cell Physiol, 10.1152/ajpcell.00192.2002
Submitted on April 24, 2002
Accepted on September 16, 2002
1 Pathology, The University of Western Ontario, London, Ontario, Canada
* To whom correspondence should be addressed. E-mail: schakrab{at}uwo.ca.
Human endothelial cells cultured under high glucose (HG) conditions were shown before to upregulate several basement membrane proteins, including fibronectin (FN); thus mimicking effects of diabetes. Using a human macrovascular (HUVEC) and a microvascular (HMEC) endothelial cell lines, we evaluated in the present study, some of the key molecular signaling events involved in HG-induced FN overexpression. This expression was shown to be dependent on endogenous endothelin (ET)-receptor-mediated signaling. We also examined the roles played by protein kinase-C (PKC), and the transcription factors nuclear factor kappa -
B (NF-
B) and activating protein (AP)-1 with respect to such changes. HG, PKC activators and ETs (ET-1 and ET-3) which increased FN expression also caused activation of NF-
B and AP-1. Inhibitors of both NF-
B and AP-1 prevented HG- and ET-induced FN production. ET-receptor blockade also prevented these HG-and ET-mediated changes. The results of this study indicate that glucose-induced increased FN production in diabetes may be mediated via ET-dependent NF-
B and AP-1 activation.
This article has been cited by other articles:
![]() |
F. Peng, D. Wu, B. Gao, A. J. Ingram, B. Zhang, K. Chorneyko, R. McKenzie, and J. C. Krepinsky RhoA/Rho-Kinase Contribute to the Pathogenesis of Diabetic Renal Disease Diabetes, June 1, 2008; 57(6): 1683 - 1692. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Feng, S. Chen, J. Chiu, B. George, and S. Chakrabarti Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level Am J Physiol Endocrinol Metab, June 1, 2008; 294(6): E1119 - E1126. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Xin, S. Chen, Z. A. Khan, and S. Chakrabarti Akt activation and augmented fibronectin production in hyperhexosemia Am J Physiol Endocrinol Metab, October 1, 2007; 293(4): E1036 - E1044. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. He, A. Dibas, T. Yorio, and G. Prasanna Parallel Signaling Pathways in Endothelin-1-Induced Proliferation of U373MG Astrocytoma Cells Experimental Biology and Medicine, March 1, 2007; 232(3): 370 - 384. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kaur, S. Chen, X. Xin, J. Chiu, Z. A. Khan, and S. Chakrabarti Diabetes-Induced Extracellular Matrix Protein Expression Is Mediated by Transcription Coactivator p300 Diabetes, November 1, 2006; 55(11): 3104 - 3111. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Qi, X. Chen, J. Holian, E. Mreich, S. Twigg, R. E. Gilbert, and C. A. Pollock Transforming growth factor-beta1 differentially mediates fibronectin and inflammatory cytokine expression in kidney tubular cells Am J Physiol Renal Physiol, November 1, 2006; 291(5): F1070 - F1077. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. A. Khan, H. Farhangkhoee, J. L. Mahon, L. Bere, J. R. Gonder, B. M. Chan, S. Uniyal, and S. Chakrabarti Endothelins: regulators of extracellular matrix protein production in diabetes. Experimental Biology and Medicine, June 1, 2006; 231(6): 1022 - 1029. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Li, T. Sawamura, and G. Renier Glucose Enhances Human Macrophage LOX-1 Expression: Role for LOX-1 in Glucose-Induced Macrophage Foam Cell Formation Circ. Res., April 16, 2004; 94(7): 892 - 901. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chen, Z. A. Khan, M. Cukiernik, and S. Chakrabarti Differential activation of NF-kappa B and AP-1 in increased fibronectin synthesis in target organs of diabetic complications Am J Physiol Endocrinol Metab, June 1, 2003; 284(6): E1089 - E1097. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |